Gene: GPCPD1
Official Full Name: glycerophosphocholine phosphodiesterase 1provided by HGNC
Gene Summary: Predicted to enable glycerophosphocholine phosphodiesterase activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within skeletal muscle tissue development. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17307 | GPCPD1 Knockout cell line (HeLa) | Human | GPCPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO17308 | GPCPD1 Knockout cell line (HCT 116) | Human | GPCPD1 | 1:2~1:4 | Negative | Online Inquiry |
KO17309 | GPCPD1 Knockout cell line (HEK293) | Human | GPCPD1 | 1:3~1:6 | Negative | Online Inquiry |
KO17310 | GPCPD1 Knockout cell line (A549) | Human | GPCPD1 | 1:3~1:4 | Negative | Online Inquiry |
GPCPD1 Gene Knockout Cell Lines represent a powerful biological tool designed for researchers exploring the diverse functionalities of the GPCPD1 gene, which is implicated in glycerol-3-phosphate metabolism and cellular signaling pathways. These cell lines feature a complete ablation of the GPCPD1 gene, allowing researchers to study the consequences of its loss on cellular physiology, metabolic processes, and gene expression profiles.
The primary function of GPCPD1 in cellular contexts involves its pivotal role in synthesizing glycerol-3-phosphate, a key intermediate in lipid biosynthesis and energy metabolism. By utilizing GPCPD1 Gene Knockout Cell Lines, scientists can investigate the downstream effects of GPCPD1 depletion on lipid accumulation, mitochondrial function, and overall cellular health. This is critical for understanding various metabolic disorders, including obesity, diabetes, and other lipid-related diseases.
The scientific importance of these knockout cell lines is underscored by their applications in fundamental research as well as translational medicine. They serve as an invaluable resource for drug discovery, allowing investigators to identify potential therapeutic targets linked to GPCPD1 activity. In clinical settings, these models can also facilitate the exploration of personalized medicine approaches, where understanding the role of specific genes in diseases could guide tailored treatment strategies.
What sets GPCPD1 Gene Knockout Cell Lines apart from other genetic models is their rigorous validation, ensuring a high level of consistency and reproducibility in experimental outcomes. Moreover, these cell lines are easy to culture and feature robust performance in a variety of assays, making them ideal for both academic and industrial laboratories.
Furthermore, the use of our GPCPD1 Gene Knockout Cell Lines significantly enhances experimental accuracy, provides insights into metabolic regulations, and aids in the identification of novel biomarkers, all of which are valuable to researchers and clinicians striving to uncover the intricate molecular underpinnings of disease.
Our company prides itself on its extensive expertise in the development and supply of specialized biological products, ensuring that researchers have access to high-quality tools that meet their rigorous scientific needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.